Study finds three doses of Pfizer COVID vaccine better than two
The study, published in The Lancet Regional Health-Americas, assessed the effectiveness of two doses of the Pfizer COVID-19…
Author
Novel antibody helps block COVID transmission in cells, finds study
The antibody, FuG1, targets the enzyme furin, which the virus uses for its efficient chain of infections in human cells
Decision on third dose of COVID-19 vaccine for all adults will be based on scientific need:…
Responding to a question at a weekly press conference, Dr V K Paul, Member (health), NITI Aayog, said all decisions on precaution…
DTAB recommends granting licence to manufacture, stock new drugs, jabs under clinical trial
Various industry experts and subject experts are of opinion that if the government approves recommendation of DTAB and DCGI, it…
India’s first homegrown mRNA COVID-19 vaccine currently under final clinical trial stages:…
The vaccine is being developed by Pune-based Gennova Biopharmaceuticals, informed Dr VK Paul, Member (health), NITI Aayog
IIT Jodhpur researchers identify COVID-19 RNA variations and their implications
The scientists have also studied the fixation of these intra-host variations into extra-host variations and mutations that lead to…
New antiviral drug combo highly effective against coronavirus: Study
The research, published recently in the journal Nature, suggests that these drugs are more potent when used in combination than…
ICMR has collected over Rs 171 crores as royalty from Covaxin’s sales: Government
The ICMR has spent around Rs 35 crores in research and development of Covaxin
DCGI gives nod to SII’s proposal to manufacture vaccine against omicron for test and analysis
Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, had put in an application to the DCGI on 6th January…
Indian scientists claim to have designed vaccine against all variants of coronavirus
With new variants of the SARS-COV-2 virus triggering fresh waves of the highly infectious disease, scientists at the Kazi Nazrul…